Company / Cash per Share
ResMed Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$8.23
FY2025
5-year range
$1.56 / $8.23
FY2021-FY2025
Trend
+408.0%
vs FY2024
Sector context
#31 of 150
Health Care
What the data says
Cash per Share changed +408% YoY in FY2025, a notable deviation from the 9-year average annual change of +53%.
Based on SEC 10-K filings.
8.23 in FY2025 with a 5-year CAGR of +20.6%. Top quartile in the Health Care sector.
Improved from $1.56 to $8.23 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +63.6%
- 5-Year CAGR
- +20.6%
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 150This company $8.23 Sector average $27.04
▼
-69.6% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 408.0% year-over-year.
- Ranks #31 out of 150 companies in the Health Care sector.
- Lowest cash per share in the period was in FY2019.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.23 | +408.0% |
| FY2024 | $1.62 | +4.1% |
| FY2023 | $1.56 | -17.2% |
| FY2022 | $1.88 | -7.8% |
| FY2021 | $2.04 | -36.8% |
| FY2020 | $3.22 | +212.7% |
| FY2019 | $1.03 | -22.3% |
| FY2018 | $1.33 | -77.3% |
| FY2017 | $5.84 | +12.2% |
| FY2016 | $5.21 | +1.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026